HPRT and purine salvaging are critical for hematopoietic stem cell function
peer-reviewed
Erstveröffentlichung
2019-10-01Autoren
Vogel, Mona
Möhrle, Bettina Maria
Brown, Andreas
Eiwen, Karina
Sakk, Vadim
Wissenschaftlicher Artikel
Erschienen in
Stem Cells ; 37 (2019), 12. - S. 1606-1614. - ISSN 1066-5099. - eISSN 1549-4918
Link zur Originalveröffentlichung
https://dx.doi.org/10.1002/stem.3087Institutionen
Zentralinstitut für Biomedizinische Technik (ZIBMT)Externe Kooperationen
University of CincinnatiDokumentversion
Veröffentlichte Version (Verlags-PDF)Zusammenfassung
Adult hematopoietic stem cells (HSCs) maintain tissue homeostasis and regenerative capacity of the hematopoietic system through self‐renewal and differentiation. Metabolism is recognized as an important regulatory entity controlling stem cells. As purine nucleotides are essential for metabolic functions, we analyzed the role of hypoxanthine guanine phosphoribosyl transferase (HPRT)‐associated purine salvaging in HSCs. Here, we demonstrate that hematopoietic stem and progenitor cells (HSPCs) show a strong dependence on HPRT‐associated purine salvaging. HSPCs with lower HPRT activity had a severely reduced competitive repopulation ability upon transplantation. Strikingly, HPRT deficiency resulted in altered cell‐cycle progression, proliferation kinetics and mitochondrial membrane potential primarily in the HSC compartment, whereas more committed progenitors were less affected. Our data thus imply a unique and important role of HPRT and the purine salvage pathway for HSC function. stem cells 2019;37:1606–1614 Free purine bases are recycled by the purine salvaging enzyme hypoxanthine guanine phosphoribosyl transferase (HPRT) (left). A reduced activity of HPRT alters cell‐cycle progression and function of mitochondria (right) in hematopoietic stem cells (HSCs), which is linked to reduced HSC repopulation ability upon transplantation. Our data suggest that an elevated level of purine degradation products might initiate these phenotypes in HSCs in which HPRT activity is reduced.
DFG-Projekt uulm
SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187
SFB 1279 / Nutzung des menschlichen Peptidoms für die Entwicklung neuer antimikrobieller und anti-Krebs Therapeutika / DFG / 316249678
GRK 1789 / CEMMA / Zelluläre und molekulare Mechanismen der Alterung / DFG / 194266605
SFB 1279 / Nutzung des menschlichen Peptidoms für die Entwicklung neuer antimikrobieller und anti-Krebs Therapeutika / DFG / 316249678
GRK 1789 / CEMMA / Zelluläre und molekulare Mechanismen der Alterung / DFG / 194266605
Wird ergänzt durch
https://stemcellsjournals.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fstem.3087&file=stem3087-sup-0001-Supinfo.docxhttps://stemcellsjournals.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fstem.3087&file=stem3087-sup-0002-FigureS1.tiff
https://stemcellsjournals.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fstem.3087&file=stem3087-sup-0003-FigureS2.tiff
Schlagwörter
[GND]: Blutstammzelle | Nucleotide | DNS | Lesch-Nyhan-Syndrom[LCSH]: Biosynthesis
[MeSH]: Hematopoietic stem cells | Stem cells | Mitochondria | Cell cycle | Nucleotides | DNA | Lesch-Nyhan Syndrome
[Freie Schlagwörter]: Hematopoietic stem and progenitor cells (HSPCs) | Purine nucleotide metabolism | HPRT-associated purine salvaging | Proliferation kinetics | Mitochondria function
[DDC Sachgruppe]: DDC 570 / Life sciences | DDC 610 / Medicine & health | DDC 620 / Engineering & allied operations
Metadata
Zur LanganzeigeDOI & Zitiervorlage
Nutzen Sie bitte diesen Identifier für Zitate & Links: http://dx.doi.org/10.18725/OPARU-40037
Vogel, Mona et al. (2021): HPRT and purine salvaging are critical for hematopoietic stem cell function. Open Access Repositorium der Universität Ulm und Technischen Hochschule Ulm. http://dx.doi.org/10.18725/OPARU-40037
Verschiedene Zitierstile >